FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (ESCITSLOPRAM), a generic antidepressant, bringing a generic version to market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITSLOPRAM)